Wang H, Han J, Zhang X
Gut Microbes. 2025; 17(1):2467213.
PMID: 39960310
PMC: 11834532.
DOI: 10.1080/19490976.2025.2467213.
Yang Z, Lin Z, You Y, Zhang M, Gao N, Wang X
Adv Sci (Weinh). 2024; 12(10):e2412071.
PMID: 39737849
PMC: 11905087.
DOI: 10.1002/advs.202412071.
Ren T, Xu M, Du X, Wang Y, Loor J, Lei L
Int J Mol Sci. 2024; 25(15).
PMID: 39125935
PMC: 11313175.
DOI: 10.3390/ijms25158365.
Wang S, Yang Y, Jiang X, Zheng X, Wei Q, Dai W
Cell Death Discov. 2024; 10(1):271.
PMID: 38830900
PMC: 11148167.
DOI: 10.1038/s41420-024-02043-x.
Yang M, Zheng X, Fan J, Cheng W, Yan T, Lai Y
Adv Sci (Weinh). 2024; 11(28):e2307981.
PMID: 38713722
PMC: 11267274.
DOI: 10.1002/advs.202307981.
Potential Molecular Mechanisms of Alcohol Use Disorder with Non-Coding RNAs and Gut Microbiota for the Development of Superior Therapeutic Application.
Nakashima M, Suga N, Yoshikawa S, Ikeda Y, Matsuda S
Genes (Basel). 2024; 15(4).
PMID: 38674366
PMC: 11049149.
DOI: 10.3390/genes15040431.
Systematic assessment of transcriptomic and metabolic reprogramming by blue light exposure coupled with aging.
Huang J, Zhou F, Zhou H, Zheng X, Huo Z, Yang M
PNAS Nexus. 2023; 2(12):pgad390.
PMID: 38059264
PMC: 10697416.
DOI: 10.1093/pnasnexus/pgad390.
Gut microbiota: key facilitator in metastasis of colorectal cancer.
Yu S, Wang S, Xiong B, Peng C
Front Oncol. 2023; 13:1270991.
PMID: 38023192
PMC: 10643165.
DOI: 10.3389/fonc.2023.1270991.
m5U-GEPred: prediction of RNA 5-methyluridine sites based on sequence-derived and graph embedding features.
Xu Z, Wang X, Meng J, Zhang L, Song B
Front Microbiol. 2023; 14:1277099.
PMID: 37937221
PMC: 10627201.
DOI: 10.3389/fmicb.2023.1277099.
Antibiotic-Induced Dysbiosis of the Gut Microbiota Impairs Gene Expression in Gut-Liver Axis of Mice.
Liu P, Zhang Y, Zhang Z, Huang X, Su X, Yang S
Genes (Basel). 2023; 14(7).
PMID: 37510327
PMC: 10379678.
DOI: 10.3390/genes14071423.
Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy.
Gao J, Fang Y, Chen J, Tang Z, Tian M, Jiang X
Oncogene. 2023; 42(33):2507-2520.
PMID: 37420030
DOI: 10.1038/s41388-023-02760-0.
Post-stroke depression: epigenetic and epitranscriptomic modifications and their interplay with gut microbiota.
Jeong S, Chokkalla A, Davis C, Vemuganti R
Mol Psychiatry. 2023; 28(10):4044-4055.
PMID: 37188778
PMC: 10646155.
DOI: 10.1038/s41380-023-02099-8.
Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome.
Liu K, He X, Huang J, Yu S, Cui M, Gao M
Clin Epigenetics. 2023; 15(1):86.
PMID: 37179374
PMC: 10183145.
DOI: 10.1186/s13148-023-01487-9.
Roles and therapeutic implications of m6A modification in cancer immunotherapy.
Pan J, Huang T, Deng Z, Zou C
Front Immunol. 2023; 14:1132601.
PMID: 36960074
PMC: 10028070.
DOI: 10.3389/fimmu.2023.1132601.
Epitranscriptome profiling of spleen mRNA mA methylation reveals pathways of host responses to malaria parasite infection.
Wang L, Wu J, Liu R, Chen W, Pang Z, Zhou F
Front Immunol. 2022; 13:998756.
PMID: 36203583
PMC: 9531237.
DOI: 10.3389/fimmu.2022.998756.
The Potential Role of mA in the Regulation of TBI-Induced BGA Dysfunction.
Huang P, Liu M, Zhang J, Zhong X, Zhong C
Antioxidants (Basel). 2022; 11(8).
PMID: 36009239
PMC: 9405408.
DOI: 10.3390/antiox11081521.
The Maternal Microbiome Programs the mA Epitranscriptome of the Mouse Fetal Brain and Intestine.
Xiao Z, Liu S, Li Z, Cui J, Wang H, Wang Z
Front Cell Dev Biol. 2022; 10:882994.
PMID: 35874829
PMC: 9301011.
DOI: 10.3389/fcell.2022.882994.
Attenuated Duck Hepatitis A Virus Infection Is Associated With High mRNA Maintenance in Duckling Liver m6A Modification.
Wu L, Quan W, Zhang Y, Wang M, Ou X, Mao S
Front Immunol. 2022; 13:839677.
PMID: 35757688
PMC: 9218207.
DOI: 10.3389/fimmu.2022.839677.
YTHDF1 Negatively Regulates -Induced Inflammation in THP-1 Macrophages by Promoting SOCS3 Translation in an m6A-Dependent Manner.
Li Z, Teng M, Jiang Y, Zhang L, Luo X, Liao Y
Front Immunol. 2022; 13:857727.
PMID: 35444649
PMC: 9013966.
DOI: 10.3389/fimmu.2022.857727.
Targeting the RNA mA modification for cancer immunotherapy.
Li X, Ma S, Deng Y, Yi P, Yu J
Mol Cancer. 2022; 21(1):76.
PMID: 35296338
PMC: 8924732.
DOI: 10.1186/s12943-022-01558-0.